Development of prognostic predictive model with neutrophil-lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma

被引:5
作者
Yang, Shihai [1 ]
Li, Shangdong [1 ]
机构
[1] Inner Mongolia Med Univ, Neimenggu Baogang Hosp, Dept Surg Oncol, Baotou 014040, Peoples R China
关键词
GSRC; neutrophil-lymphocyte ratio; prognosis; PREOPERATIVE NEUTROPHIL; CANCER; SURVIVAL; ADENOCARCINOMA; EXPRESSION; CYTOKINES; CELLS;
D O I
10.1097/MD.0000000000028043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk factors have not been well-defined for prognosis in gastric signet ring cell carcinoma (GSRC) patients. This study is designed to prognosticate survival in GSRC patients by establishing and verifying a predictive model with neutrophil-lymphocyte ratio (NLR). A total of 147 GSRC patients from Department of Surgical Oncology, Neimenggu Baogang Hospital, Inner Mongolia Medical University were retrospectively reviewed. A predictive model was established using Cox proportional hazards. The performance of the model was evaluated by ROC curves. In present study, we found that overall survival (OS) (P < .001, Fig. 1A) and tumor recurrence rate (P= .036, Fig. 1B) in the NLR < 2.8 group were significantly better than those in the NLR > 2.8 group. These results showed that NLR < 2.8 was significant prognostic factor related with both OS and tumor recurrence in patients with GSRC. After adjusting for competing risk factors, NLR < 2.8 (hazard ratio [HR]: 2.625, 95% confidence interval [CI]: 1.505-5.3166, P = .003), tumor size (HR: 3.024, 95% CI: 1.521-4.186, P = .005), and tumor metastasis (HR: 3.303, 95% CI: 1.25-4.525, P= .012) remained independent predictors of tumor recurrence rate and OS. Our results showed that comparing with the model without NLR (area under ROC curve: 0.798), the model with NLR (area under ROC curve: 0.826) had significant better predictive power than the model without NLR, which further confirmed the value of NLR in predicting prognosis of patients with GSRC. In conclusion, a high NLR value independently predicts poor survival in patients with GSRC after surgery. The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy in order to choose alternative therapies for patients with high NLR value.
引用
收藏
页数:5
相关论文
共 30 条
[21]   Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy [J].
Li, Yang ;
Zhu, Zhikai ;
Ma, Fuhai ;
Xue, Liyan ;
Tian, Yantao .
CANCER MEDICINE, 2020, 9 (18) :6617-6628
[22]   Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States [J].
Lin, Chun-Lin ;
Zhu, Guang-Wei ;
Huang, Yong-Jian ;
Zheng, Wei ;
Yang, Shu-Gang ;
Ye, Jian-Xin .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2020, 26 (01) :46-52
[23]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[24]   Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape [J].
Salazar-Onfray, Flavio ;
Lopez, Mercedes N. ;
Mendoza-Naranjo, Ariadna .
CYTOKINE & GROWTH FACTOR REVIEWS, 2007, 18 (1-2) :171-182
[25]  
Schröder W, 2017, CHIRURG, V88, DOI 10.1007/s00104-017-0478-0
[26]   Gastric signet ring cell adenocarcinoma: A distinct entity [J].
Tabouret, Tessa ;
Dhooge, Marion ;
Rouquette, Alexandre ;
Brezault, Catherine ;
Beuvon, Frederic ;
Chaussade, Stanislas ;
Coriat, Romain .
PRESSE MEDICALE, 2014, 43 (04) :353-357
[27]   Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer [J].
Vartolomei, Mihai Dorin ;
Ferro, Matteo ;
Cantiello, Francesco ;
Lucarelli, Giuseppe ;
Di Stasi, Savino ;
Hurle, Rodolfo ;
Guazzoni, Gioyo ;
Busetto, Gian Maria ;
De Berardinis, Ettore ;
Damiano, Rocco ;
Perdona, Sisto ;
Verze, Paolo ;
La Rocca, Roberto ;
Borghesi, Marco ;
Schiavina, Riccardo ;
Brunocilla, Eugenio ;
Almeida, Gilberto L. ;
Bove, Pierluigi ;
Lima, Estevao ;
Grimaldi, Giovanni ;
Autorino, Riccardo ;
Crisan, Nicolae ;
Abu Farhan, Abdal Rahman ;
Battaglia, Michele ;
Serretta, Vincenzo ;
Russo, Giorgio Ivan ;
Morgia, Giuseppe ;
Terracciano, Daniela ;
Musi, Gennaro ;
de Cobelli, Ottavio ;
Mirone, Vincenzo ;
Shariat, Shahrokh F. .
CLINICAL GENITOURINARY CANCER, 2018, 16 (06) :445-452
[28]   Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis [J].
Vartolomei, Mihai Dorin ;
Porav-Hodade, Daniel ;
Ferro, Matteo ;
Mathieu, Romain ;
Abufaraj, Mohammad ;
Foerster, Beat ;
Kimura, Shoji ;
Shariat, Shahrokh F. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (09) :389-399
[29]   Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy [J].
Vartolomei, Mihai Dorin ;
Mathieu, Romain ;
Margulis, Vitaly ;
Karam, Jose A. ;
Rouprt, Morgan ;
Lucca, Ilaria ;
Mbeutcha, Aurelie ;
Seitz, Christian ;
Karakiewicz, Pierre I. ;
Fajkovic, Harun ;
Wood, Christopher G. ;
Weizer, Alon Z. ;
Raman, Jay D. ;
Rioux-Leclercq, Nathalie ;
Haitel, Andrea ;
Bensalah, Karim ;
Rink, Michael ;
Briganti, Alberto ;
Xylinas, Evanguelos ;
Shariat, Shahrokh F. .
WORLD JOURNAL OF UROLOGY, 2017, 35 (01) :121-130
[30]  
Xiong ZF, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029181